Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study.

Antoniou T, Yao Z, Raboud J, Gershon AS.

CMAJ Open. 2020 Feb 18;8(1):E83-E89. doi: 10.9778/cmajo.20190028. Print 2020 Jan-Mar.

2.

Cardiovascular consequences of obstructive sleep apnea in women: a historical cohort study.

Kendzerska T, Leung RS, Atzema CL, Chandy G, Meteb M, Malhotra A, Hawker GA, Gershon AS.

Sleep Med. 2019 Sep 11;68:71-79. doi: 10.1016/j.sleep.2019.08.021. [Epub ahead of print]

PMID:
32028229
3.

Prevalence of comorbidities and impact on pulmonary rehabilitation outcomes.

Butler SJ, Li LSK, Ellerton L, Gershon AS, Goldstein RS, Brooks D.

ERJ Open Res. 2019 Dec 8;5(4). pii: 00264-2019. doi: 10.1183/23120541.00264-2019. eCollection 2019 Oct.

4.

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.

Fisher JH, Kolb M, Algamdi M, Morisset J, Johannson KA, Shapera S, Wilcox P, To T, Sadatsafavi M, Manganas H, Khalil N, Hambly N, Halayko AJ, Gershon AS, Fell CD, Cox G, Ryerson CJ.

BMC Pulm Med. 2019 Nov 27;19(1):223. doi: 10.1186/s12890-019-0986-4.

5.

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.

Tavakoli H, Johnson KM, FitzGerald JM, Sin DD, Gershon AS, Kendzerska T, Sadatsafavi M.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:2003-2013. doi: 10.2147/COPD.S210897. eCollection 2019.

6.

Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Vozoris NT, Yao Z, Li P, Austin PC, Stephenson AL, Gill SS, O'Donnell DE, Gershon AS, Rochon PA.

Drugs Aging. 2019 Nov;36(11):1035-1045. doi: 10.1007/s40266-019-00707-3.

PMID:
31552597
7.

Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.

Gershon AS, Chung H, Porter J, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Campigotto A, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor AE, Smieja M, Zahariadis G, Kwong JC.

J Infect Dis. 2020 Jan 1;221(1):42-52. doi: 10.1093/infdis/jiz419.

PMID:
31549165
8.

End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer.

Kendzerska T, Nickerson JW, Hsu AT, Gershon AS, Talarico R, Mulpuru S, Pakhale S, Tanuseputro P.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 31;14:1691-1701. doi: 10.2147/COPD.S210916. eCollection 2019.

9.

Using wearables and self-management apps in patients with COPD: a qualitative study.

Wu RC, Ginsburg S, Son T, Gershon AS.

ERJ Open Res. 2019 Sep 10;5(3). pii: 00036-2019. doi: 10.1183/23120541.00036-2019. eCollection 2019 Jul.

10.

Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.

Kendzerska T, Aaron SD, To T, Licskai C, Stanbrook M, Vozoris NT, Hogan ME, Tan WC, Bourbeau J, Gershon AS.

Ann Am Thorac Soc. 2019 Oct;16(10):1252-1262. doi: 10.1513/AnnalsATS.201902-126OC.

PMID:
31298938
11.

Patterns of health care use related to respiratory conditions in early life: A birth cohort study with linked administrative data.

Chen W, Subbarao P, McGihon RE, Feldman LY, Zhu J, Lou W, Gershon AS, Abdullah K, Moraes TJ, Dubeau A, Sears MR, Lefebvre DL, Turvey SE, Mandhane PJ, Azad MB, To T.

Pediatr Pulmonol. 2019 Aug;54(8):1267-1276. doi: 10.1002/ppul.24381. Epub 2019 Jun 6.

PMID:
31172683
12.

Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study.

Gershon AS, Thiruchelvam D, Aaron S, Stanbrook M, Vozoris N, Tan WC, Cho E, To T.

PLoS One. 2019 May 21;14(5):e0216741. doi: 10.1371/journal.pone.0216741. eCollection 2019.

13.

Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.

Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ.

Chest. 2019 Nov;156(5):887-895. doi: 10.1016/j.chest.2019.04.016. Epub 2019 Apr 30.

14.

Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.

Press VG, Au DH, Bourbeau J, Dransfield MT, Gershon AS, Krishnan JA, Mularski RA, Sciurba FC, Sullivan J, Feemster LC.

Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.

15.

Which Physicians Are Taking Care of People With COPD?

Cho EE, Mecredy GC, Wong HH, Stanbrook MB, Gershon AS.

Chest. 2019 Apr;155(4):771-777. doi: 10.1016/j.chest.2018.12.018. Epub 2019 Jan 18.

PMID:
30664858
16.

Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement.

Patel MR, Press VG, Gerald LB, Barnes T, Blake K, Brown LK, Costello RW, Crim C, Forshag M, Gershon AS, Goss CH, Han MK, Lee TA, Sweet S, Gerald JK.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1367-1374. doi: 10.1164/rccm.201810-1865ST.

PMID:
30601674
17.

Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).

Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS.

Ann Am Thorac Soc. 2019 Jan;16(1):71-81. doi: 10.1513/AnnalsATS.201802-136OC.

PMID:
30372124
18.

Sleep Apnea Increases the Risk of New Hospitalized Atrial Fibrillation: A Historical Cohort Study.

Kendzerska T, Gershon AS, Atzema C, Dorian P, Mangat I, Hawker G, Leung RS.

Chest. 2018 Dec;154(6):1330-1339. doi: 10.1016/j.chest.2018.08.1075. Epub 2018 Sep 19.

PMID:
30243978
19.

Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease.

Diab N, Gershon AS, Sin DD, Tan WC, Bourbeau J, Boulet LP, Aaron SD.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139. doi: 10.1164/rccm.201804-0621CI. Review.

PMID:
29979608
20.

Serotonergic antidepressant use and morbidity and mortality among older adults with COPD.

Vozoris NT, Wang X, Austin PC, Stephenson AL, O'Donnell DE, Gershon AS, Gill SS, Rochon PA.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800475. doi: 10.1183/13993003.00475-2018. Print 2018 Jul.

21.

Feasibility of Using a Smartwatch to Intensively Monitor Patients With Chronic Obstructive Pulmonary Disease: Prospective Cohort Study.

Wu R, Liaqat D, de Lara E, Son T, Rudzicz F, Alshaer H, Abed-Esfahani P, Gershon AS.

JMIR Mhealth Uhealth. 2018 Jun 14;6(6):e10046. doi: 10.2196/10046.

22.

End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease.

Gershon AS, Maclagan LC, Luo J, To T, Kendzerska T, Stanbrook MB, Bourbeau J, Etches J, Aaron SD.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1389-1396. doi: 10.1164/rccm.201803-0592OC.

PMID:
29889548
23.

Can Patients With COPD Assimilate Disease-Specific Information During an Acute Exacerbation?: Results of a Pilot Randomized Controlled Trial.

Janaudis-Ferreira T, Carr SJ, Harrison SL, Gershon AS, Milner SC, Carr S, Fishbein D, Goldstein R.

Chest. 2018 Sep;154(3):588-596. doi: 10.1016/j.chest.2018.05.028. Epub 2018 Jun 4.

PMID:
29879395
24.

Underdiagnosis and Overdiagnosis of Asthma.

Aaron SD, Boulet LP, Reddel HK, Gershon AS.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1012-1020. doi: 10.1164/rccm.201804-0682CI. Review.

PMID:
29756989
25.

Clinical Knowledge from Observational Studies. Everything You Wanted to Know but Were Afraid to Ask.

Gershon AS, Jafarzadeh SR, Wilson KC, Walkey AJ.

Am J Respir Crit Care Med. 2018 Oct 1;198(7):859-867. doi: 10.1164/rccm.201801-0118PP. Review. No abstract available.

PMID:
29733678
26.

Reply to Goulden et al.: Risk of Bias in Study of Varenicline and Cardiovascular Outcomes.

Gershon AS, Campitelli MA, Hawken S, Sproule BA, Selby P.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):691-692. doi: 10.1164/rccm.201804-0639LE. No abstract available.

PMID:
29708391
27.

Asthma health services utilisation before, during and after pregnancy: a population-based cohort study.

To T, Feldman LY, Zhu J, Gershon AS.

Eur Respir J. 2018 Apr 19;51(4). pii: 1800209. doi: 10.1183/13993003.00209-2018. Print 2018 Apr.

28.

Health Services Burden of Undiagnosed and Overdiagnosed COPD.

Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network.

Chest. 2018 Jun;153(6):1336-1346. doi: 10.1016/j.chest.2018.01.038. Epub 2018 Feb 6.

PMID:
29425675
29.

Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.

Gershon AS, Campitelli MA, Hawken S, Victor C, Sproule BA, Kurdyak P, Selby P.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):913-922. doi: 10.1164/rccm.201706-1204OC.

PMID:
29260881
30.

Home Mechanical Ventilation: A 12-Year Population-Based Retrospective Cohort Study.

Povitz M, Rose L, Shariff SZ, Leonard S, Welk B, Jenkyn KB, Leasa DJ, Gershon AS.

Respir Care. 2018 Apr;63(4):380-387. doi: 10.4187/respcare.05689. Epub 2017 Dec 5.

31.

Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease.

Lindenauer PK, Dharmarajan K, Qin L, Lin Z, Gershon AS, Krumholz HM.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1009-1017. doi: 10.1164/rccm.201709-1852OC.

32.

Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.

Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS.

Br J Clin Pharmacol. 2018 Mar;84(3):579-589. doi: 10.1111/bcp.13465. Epub 2017 Dec 6.

33.

Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study.

Gershon AS, Macdonald EM, Luo J, Austin PC, Gupta S, Sivjee K, Upshur R, Aaron SD.

Fam Pract. 2017 Nov 16;34(6):708-716. doi: 10.1093/fampra/cmx058.

PMID:
28985364
34.

The risk of mycobacterial infections associated with inhaled corticosteroid use.

Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, Jamieson FB, Marras TK.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700037. doi: 10.1183/13993003.00037-2017. Print 2017 Sep.

35.

Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study.

Kendzerska T, Gershon AS, Hawker GA, Tomlinson GA, Leung RS.

Eur Respir J. 2017 Jun 1;49(6). pii: 1601361. doi: 10.1183/13993003.01361-2016. Print 2017 Jun.

36.
37.

The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.

Tu JV, Maclagan LC, Ko DT, Atzema CL, Booth GL, Johnston S, Tu K, Lee DS, Bierman A, Hall R, Bhatia RS, Gershon AS, Tobe SW, Sanmartin C, Liu P, Chu A; CANHEART Primary Prevention Indicator Expert Panel.

CMAJ Open. 2017 Apr 25;5(2):E315-E321. doi: 10.9778/cmajo.20160139.

38.

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality.

Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

PLoS One. 2017 Mar 16;12(3):e0173830. doi: 10.1371/journal.pone.0173830. eCollection 2017.

39.

Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.

Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, Winthrop KL, Gershon AS, Kwong JC, Jamieson FB.

Emerg Infect Dis. 2017 Mar;23(3):468-476. doi: 10.3201/eid2303.161927.

40.

Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD.

Gershon AS, Newman AM, Fischer HD, Austin PC, Daneman N, Bell CM, Stephenson AL, Gill SS, Vozoris NT, Rochon PA.

COPD. 2017 Feb;14(1):105-112. doi: 10.1080/15412555.2016.1202912. Epub 2016 Oct 12.

PMID:
27732117
41.

Influence of country-level differences on COPD prevalence.

Aaron SD, Gershon AS, Gao Y, Yang J, Whitmore GA.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2305-2313. eCollection 2016.

42.
43.

The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study.

Kendzerska T, To TM, Aaron SD, Lougheed MD, Sadatsafavi M, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

J Allergy Clin Immunol. 2017 Mar;139(3):835-843. doi: 10.1016/j.jaci.2016.06.026. Epub 2016 Sep 15.

PMID:
27641119
44.

Factors associated with undiagnosed and overdiagnosed COPD.

Gershon AS, Hwee J, Chapman KR, Aaron SD, O'Donnell DE, Stanbrook MB, Bourbeau J, Tan W, Su J, Victor JC, To T.

Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23. No abstract available.

45.

Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease.

Marras TK, Campitelli MA, Kwong JC, Lu H, Brode SK, Marchand-Austin A, Gershon AS, Jamieson FB.

Eur Respir J. 2016 Sep;48(3):928-31. doi: 10.1183/13993003.00033-2016. Epub 2016 Jun 10. No abstract available.

46.

The Annual September Peak in Asthma Exacerbation Rates. Still a Reality?

Larsen K, Zhu J, Feldman LY, Simatovic J, Dell S, Gershon AS, To T.

Ann Am Thorac Soc. 2016 Feb;13(2):231-9. doi: 10.1513/AnnalsATS.201508-545OC.

PMID:
26636481
47.

The Effect of Patient Neighborhood Income Level on the Purchase of Continuous Positive Airway Pressure Treatment among Patients with Sleep Apnea.

Kendzerska T, Gershon AS, Tomlinson G, Leung RS.

Ann Am Thorac Soc. 2016 Jan;13(1):93-100. doi: 10.1513/AnnalsATS.201505-294OC.

PMID:
26473580
48.

Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey.

Bowen JM, Campbell K, Sutherland S, Bartlett A, Brooks D, Qureshi R, Goldstein R, Gershon AS, Prevost S, Samis L, Kaplan AG, Hopkins RB, MacDougald C, Nunes E, O'Reilly DJ, Goeree R.

Ont Health Technol Assess Ser. 2015 Mar 1;15(8):1-67. eCollection 2015.

49.

Health risk of air pollution on people living with major chronic diseases: a Canadian population-based study.

To T, Feldman L, Simatovic J, Gershon AS, Dell S, Su J, Foty R, Licskai C.

BMJ Open. 2015 Sep 2;5(9):e009075. doi: 10.1136/bmjopen-2015-009075.

50.

Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Vozoris NT, Wang X, Fischer HD, Gershon AS, Bell CM, Gill SS, O'Donnell DE, Austin PC, Stephenson AL, Rochon PA.

Br J Clin Pharmacol. 2016 Jan;81(1):161-70. doi: 10.1111/bcp.12762. Epub 2015 Oct 2.

Supplemental Content

Loading ...
Support Center